Stocks News

LAST PRICE
63.8100
TODAY'S CHANGE (%)
Trending Up1.4800 (2.3745%)

Bid / Lots
62.5000/ 1
Ask / Lots
63.8000/ 9
Open / Previous Close
62.1000 / 62.3300
Day Range
Low 61.4700
High 64.0100
52 Week Range
Low 50.2000
High 100.8505
Volume
798,463
above average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Yesterday
- DJ Lantheus Holdings Is Maintained at Buy by B. Riley Securities, from 1:25PM ET on Thursday Apr 18, 2024 by Dow Jones
  1:25PM ET on Thursday Apr 18, 2024 by Dow Jones
  Companies Mentioned: LNTH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/LNTH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 18, 2024 13:25 ET (17:25 GMT)
- Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time, from 8:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire
  8:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire
  Companies Mentioned: LNTH
- Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time, from 8:00AM ET on Thursday Apr 18, 2024 by Dow Jones
  8:00AM ET on Thursday Apr 18, 2024 by Dow Jones
  Companies Mentioned: LNTH
  
  Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time
  
  BEDFORD, Mass., April 18, 2024 (GLOBE NEWSWIRE) -- Lantheus Holdings, Inc. (the "Company") (NASDAQ: LNTH) today announced that it will host a conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to discuss its financial and operating results for the first quarter of 2024.
- --B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating, from 7:57AM ET on Thursday Apr 18, 2024 by MT Newswires
  7:57AM ET on Thursday Apr 18, 2024 by MT Newswires
  Companies Mentioned: LNTH
  07:57 AM EDT, 04/18/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...
Mar 28, 2024
- Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results, from 7:30AM ET on Thursday Mar 28, 2024 by GlobeNewswire
  7:30AM ET on Thursday Mar 28, 2024 by GlobeNewswire
  Companies Mentioned: BMY, LNTH, CATX

Yesterday
- --Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating, from 9:03AM ET on Thursday Apr 18, 2024 by MT Newswires
  9:03AM ET on Thursday Apr 18, 2024 by MT Newswires
  Companies Mentioned: TXG
Apr 16, 2024
- Glaukos Announces the Release of its 2023 Sustainability Report, from 4:05PM ET on Tuesday Apr 16, 2024 by Business Wire
  4:05PM ET on Tuesday Apr 16, 2024 by Business Wire
  Companies Mentioned: GKOS
Apr 11, 2024
- Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating, from 9:50AM ET on Thursday Apr 11, 2024 by MT Newswires
  9:50AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: GKOS
- Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing, from 9:20AM ET on Thursday Apr 11, 2024 by MT Newswires
  9:20AM ET on Thursday Apr 11, 2024 by MT Newswires
  Companies Mentioned: GKOS
Apr 10, 2024
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024, from 4:59PM ET on Wednesday Apr 10, 2024 by PR Newswire
  4:59PM ET on Wednesday Apr 10, 2024 by PR Newswire
  Companies Mentioned: HAE
- 10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024, from 4:05PM ET on Wednesday Apr 10, 2024 by PR Newswire
  4:05PM ET on Wednesday Apr 10, 2024 by PR Newswire
  Companies Mentioned: TXG
- Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1, from 7:00AM ET on Wednesday Apr 10, 2024 by Business Wire
  7:00AM ET on Wednesday Apr 10, 2024 by Business Wire
  Companies Mentioned: GKOS
Apr 4, 2024
- Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge, from 10:57AM ET on Thursday Apr 04, 2024 by MT Newswires
  10:57AM ET on Thursday Apr 04, 2024 by MT Newswires
  Companies Mentioned: HAE
- Haemonetics Receives FDA Clearance for New TEG(R) 6s Global Hemostasis - HN Cartridge, from 6:30AM ET on Thursday Apr 04, 2024 by PR Newswire
  6:30AM ET on Thursday Apr 04, 2024 by PR Newswire
  Companies Mentioned: HAE
Apr 3, 2024
- Sector Update: Health Care Stocks Rise Wednesday Afternoon, from 1:54PM ET on Wednesday Apr 03, 2024 by MT Newswires
  1:54PM ET on Wednesday Apr 03, 2024 by MT Newswires
  Companies Mentioned: ABIO, ASXC, GKOS

Lantheus Holdings Inc
NASDAQ:LNTHUnited States

Search Criteria

Yesterday

DJ Lantheus Holdings Is Maintained at Buy by B. Riley Securities, from 1:25PM ET on Thursday Apr 18, 2024 by Dow Jones

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time, from 8:00AM ET on Thursday Apr 18, 2024 by GlobeNewswire

Lantheus to Host First Quarter 2024 Earnings Conference Call and Webcast on May 2, 2024, at 8:00 a.m. Eastern Time, from 8:00AM ET on Thursday Apr 18, 2024 by Dow Jones

--B. Riley Raises Price Target on Lantheus Holdings to $99 From $95, Keeps Buy Rating, from 7:57AM ET on Thursday Apr 18, 2024 by MT Newswires

Mar 28, 2024

Perspective Therapeutics Provides Recent Business Highlights and Reports Fiscal Year 2023 Financial Results, from 7:30AM ET on Thursday Mar 28, 2024 by GlobeNewswire

Peers Headlines

Yesterday

--Deutsche Bank Cuts Price Target on 10x Genomics to $55 From $60, Keeps Buy Rating, from 9:03AM ET on Thursday Apr 18, 2024 by MT Newswires

Apr 16, 2024

Glaukos Announces the Release of its 2023 Sustainability Report, from 4:05PM ET on Tuesday Apr 16, 2024 by Business Wire

Apr 11, 2024

Mizuho Securities Adjusts Price Target on Glaukos to $100 From $85, Maintains Neutral Rating, from 9:50AM ET on Thursday Apr 11, 2024 by MT Newswires

Glaukos Insider Sold Shares Worth $6,008,359, According to a Recent SEC Filing, from 9:20AM ET on Thursday Apr 11, 2024 by MT Newswires

Apr 10, 2024

Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024, from 4:59PM ET on Wednesday Apr 10, 2024 by PR Newswire

10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024, from 4:05PM ET on Wednesday Apr 10, 2024 by PR Newswire

Glaukos to Release First Quarter 2024 Financial Results after Market Close on May 1, from 7:00AM ET on Wednesday Apr 10, 2024 by Business Wire

Apr 4, 2024

Haemonetics Gets FDA Clearance for New TEG 6s Global Hemostasis-HN Cartridge, from 10:57AM ET on Thursday Apr 04, 2024 by MT Newswires

Haemonetics Receives FDA Clearance for New TEG(R) 6s Global Hemostasis - HN Cartridge, from 6:30AM ET on Thursday Apr 04, 2024 by PR Newswire

Apr 3, 2024

Sector Update: Health Care Stocks Rise Wednesday Afternoon, from 1:54PM ET on Wednesday Apr 03, 2024 by MT Newswires